Compound ID | 524
MC-04112
Class: Efflux pump inhibitor
| Details of activity: | Permeates bacteria membrane to antibacterial compounds; designed for pseudomonal infections |
| Combined with other compounds: | Tested with fluoroquinolones and macrolides which demonstrated a reduction of MIC In vivo |
| Institute where first reported: | Microcide (Essential Therapeutics (Ceased)); Daiichi Sankyo Pharmaceutical, Japan |
| Year first mentioned: | 2001 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| External links: | |
| Citation: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.